Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP

Biochemical Journal

Volumn 444, Issue 3, 2012, Pages 581-590

  Dong, Xue Yuan ^a   Fu, Xiaoying ^a   Fan, Songqing ^a,b   Guo, Peng ^a   Su, Dan ^a   Dong, Jin Tang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

AT motif binding factor 1 (ATBF1); Breast cancer; E3 ubiquitin ligase; Oestrogen; Oestrogen responsive finger protein (EFP); Protein degradation

Indexed keywords

AT MOTIF BINDING FACTOR 1; ESTROGEN; ESTROGEN RESPONSIVE FINGER PROTEIN; PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CARCINOGENESIS; CONTROLLED STUDY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL LINE, TUMOR; ESTROGENS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; PROTEOLYSIS; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 84862184699     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111890     Document Type: Article

References (40)

1. Morinaga, T., Yasuda, H., Hashimoto, T., Higashio, K. and Tamaoki, T. (1991) A human α-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol. Cell. Biol. 11, 6041-6049 (Pubitemid 21895375)
2. Mori, Y., Kataoka, H., Miura, Y., Kawaguchi, M., Kubota, E., Ogasawara, N., Oshima, T., Tanida, S., Sasaki, M., Ohara, H. et al. (2007) Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. Int. J. Cancer 121, 241-247 (Pubitemid 46917691)
3. Kaspar, P., Dvorakova, M., Kralova, J., Pajer, P., Kozmik, Z. and Dvorak, M. (1999) Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J. Biol. Chem. 274, 14422-14428
4. Xu, J., Sauvageot, J., Ewing, C. M., Sun, J., Liu, W., Isaacs, S. D., Wiley, K. E., Diaz, L., Zheng, S. L., Walsh, P. C. and Isaacs, W. B. (2006) Germline ATBF1 mutations and prostate cancer risk. Prostate 66, 1082-1085 (Pubitemid 43939212)
5. Cleton-Jansen, A. M., van Eijk, R., Lombaerts, M., Schmidt, M. K., Van't Veer, L. J., Philippo, K., Zimmerman, R. M., Peterse, J. L., Smit, V. T., van Wezel, T. and Cornelisse, C. J. (2008) ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism. BMC Cancer 8, 105
6. Kai, K., Zhang, Z., Yamashita, H., Yamamoto, Y., Miura, Y. and Iwase, H. (2008) Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer. BMC Cancer 8, 262
7. Sun, X., Zhou, Y., Otto, K. B., Wang, M., Chen, C., Zhou, W., Subramanian, K., Vertino, P. M. and Dong, J. T. (2007) Infrequent mutation of ATBF1 in human breast cancer. J. Cancer Res. Clin. Oncol. 133, 103-105 (Pubitemid 44950242)
8. Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Ando, Y., Mita, K., Hamaguchi, M., Kawaguchi, M., Miura, Y. and Iwase, H. (2005) ATBF1: a messenger RNA expression is correlated with better prognosis in breast cancer. Clin. Cancer Res. 11, 193-198 (Pubitemid 40075795)
9. Dong, X. Y., Guo, P., Sun, X., Li, Q. and Dong, J. T. (2011) Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-α-positive breast cancer cells. J. Biol. Chem. 286, 13879-13890
10. Dong, X. Y., Sun, X., Guo, P., Li, Q., Sasahara, M., Ishii, Y. and Dong, J. T. (2010) ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells. J. Biol. Chem. 285, 32801-32809
11. Torres-Arzayus, M. I., Font de Mora, J., Yuan, J., Vazquez, F., Bronson, R., Rue, M., Sellers, W. R. and Brown, M. (2004) High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6, 263-274 (Pubitemid 39222039)
12. Zhang, H., Yi, X., Sun, X., Yin, N., Shi, B., Wu, H., Wang, D., Wu, G. and Shang, Y. (2004) Differential gene regulation by the SRC family of coactivators. Genes Dev. 18, 1753-1765 (Pubitemid 38938190)
13. Zhang, H., Sun, L., Liang, J., Yu, W., Zhang, Y., Wang, Y., Chen, Y., Li, R., Sun, X. and Shang, Y. (2006) The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J. 25, 4223-4233 (Pubitemid 44435220)
14. Hershko, A. and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (Pubitemid 28411135)
15. Pickart, C. M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533
16. Zhang, J., Guenther, M. G., Carthew, R. W. and Lazar, M. A. (1998) Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev. 12, 1775-1780 (Pubitemid 28304330)
17. Ikeda, K., Orimo, A., Higashi, Y., Muramatsu, M. and Inoue, S. (2000) Efp as a primary estrogen-responsive gene in human breast cancer. FEBS Lett. 472, 9-13 (Pubitemid 30224576)
18. Inoue, S., Orimo, A., Hosoi, T., Kondo, S., Toyoshima, H., Kondo, T., Ikegami, A., Ouchi, Y., Orimo, H. and Muramatsu, M. (1993) Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. Proc. Natl. Acad. Sci. U.S.A. 90, 11117-11121 (Pubitemid 23354380)
19. Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y. and Inoue, S. (2002) Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth. Nature 417, 871-875
20. Suzuki, T., Urano, T., Tsukui, T., Horie-Inoue, K., Moriya, T., Ishida, T., Muramatsu, M., Ouchi, Y., Sasano, H. and Inoue, S. (2005) Estrogen-responsive finger protein as a new potential biomarker for breast cancer. Clin. Cancer Res. 11, 6148-6154 (Pubitemid 41262941)
21. Chen, C., Sun, X., Guo, P., Dong, X. Y., Sethi, P., Cheng, X., Zhou, J., Ling, J., Simons, J. W., Lingrel, J. B. and Dong, J. T. (2005) Human Krüppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J. Biol. Chem. 280, 41553-41561 (Pubitemid 41832217)
22. Zou, W. and Zhang, D. E. (2006) The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281, 3989-3994 (Pubitemid 43847823)
23. Dong, X. Y., Chen, C., Sun, X., Guo, P., Vessella, R. L., Wang, R. X., Chung, L. W., Zhou, W. and Dong, J. T. (2006) FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res. 66, 6998-7006 (Pubitemid 44197675)
24. Dong, X. Y., Rodriguez, C., Guo, P., Sun, X., Talbot, J. T., Zhou, W., Petros, J., Li, Q., Vessella, R. L., Kibel, A. S. et al. (2008) SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum. Mol. Genet. 17, 1031-1042 (Pubitemid 351426037)
25. McCarty, Jr, K. S., Miller, L. S., Cox, E. B., Konrath, J. and McCarty, Sr, K. S. (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109, 716-721 (Pubitemid 16237466)
26. Cottone, E., Orso, F., Biglia, N., Sismondi, P. and De Bortoli, M. (2001) Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity. Int. J. Biol. Markers 16, 151-166 (Pubitemid 33039920)
27. Zhao, K. W., Sikriwal, D., Dong, X., Guo, P., Sun, X. and Dong, J. T. (2011) Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells. Biochem. J. 437, 323-333
28. Orimo, A., Inoue, S., Minowa, O., Tominaga, N., Tomioka, Y., Sato, M., Kuno, J., Hiroi, H., Shimizu, Y., Suzuki, M. et al. (1999) Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor α. Proc. Natl. Acad. Sci. U.S.A. 96, 12027-12032 (Pubitemid 29502852)
29. Ueyama, K., Ikeda, K., Sato, W., Nakasato, N., Horie-Inoue, K., Takeda, S. and Inoue, S. (2010) Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth. Cancer Gene Ther. 17, 624-632
30. Gack, M. U., Shin, Y. C., Joo, C. H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S. and Jung, J. U. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (Pubitemid 46633167)
31. Thomson, S. D., Ali, S., Pickles, L., Taylor, J., Pace, P. E., Lymboura, M., Shousha, S. and Coombes, R. C. (2001) Analysis of estrogen-responsive finger protein expression in benign and malignant human breast. Int. J. Cancer 91, 152-158 (Pubitemid 32041733)
32. Brisken, C. and O'Malley, B. (2010) Hormone action in the mammary gland. Cold Spring Harb. Perspect. Biol. 2, a003178
33. Ido, A., Miura, Y. and Tamaoki, T. (1994) Activation of ATBF1, a multiple-homeodomain zinc-finger gene, during neuronal differentiation of murine embryonal carcinoma cells. Dev. Biol. 163, 184-187 (Pubitemid 24188882)
34. Ikeda, K., Inoue, S., Orimo, A., Sano, M., Watanabe, T., Tsutsumi, K. and Muramatsu, M. (1997) Multiple regulatory elements and binding proteins of the 5′-flanking region of the human estrogen-responsive finger protein (efp) gene. Biochem. Biophys. Res. Commun. 236, 765-771 (Pubitemid 27384706)
35. Nakajima, A., Maruyama, S., Bohgaki, M., Miyajima, N., Tsukiyama, T., Sakuragi, N. and Hatakeyama, S. (2007) Ligand-dependent transcription of estrogen receptor α is mediated by the ubiquitin ligase EFP. Biochem. Biophys. Res. Commun. 357, 245-251 (Pubitemid 46574523)
36. Shimada, N., Suzuki, T., Inoue, S., Kato, K., Imatani, A., Sekine, H., Ohara, S., Shimosegawa, T. and Sasano, H. (2004) Systemic distribution of estrogen-responsive finger protein (Efp) in human tissues. Mol. Cell. Endocrinol. 218, 147-153 (Pubitemid 38569935)
37. Watanabe, M., Miura, Y., Ido, A., Sakai, M., Nishi, S., Inoue, Y., Hashimoto, T. and Tamaoki, T. (1996) Developmental changes in expression of the ATBF1 transcription factor gene. Brain Res. 42, 344-349 (Pubitemid 27035765)
38. Horie, K., Urano, T., Ikeda, K. and Inoue, S. (2003) Estrogen-responsive RING finger protein controls breast cancer growth. J. Steroid Biochem. Mol. Biol. 85, 101-104 (Pubitemid 37011088)
39. Sakuma, M., Akahira, J., Suzuki, T., Inoue, S., Ito, K., Moriya, T., Sasano, H., Okamura, K. and Yaegashi, N. (2005) Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer. Gynecol. Oncol. 99, 664-670 (Pubitemid 41686551)
40. Yager, J. D. and Davidson, N. E. (2006) Estrogen carcinogenesis in breast cancer. New Engl. J. Med. 354, 270-282